126 related articles for article (PubMed ID: 26251997)
1. Oncolytic adenovirus‑mediated mda‑7/IL‑24 expression suppresses osteosarcoma growth and enhances sensitivity to doxorubicin.
Liu Z; Xu L; Yuan H; Zhang Y; Zhang X; Zhao D
Mol Med Rep; 2015 Oct; 12(4):6358-64. PubMed ID: 26251997
[TBL] [Abstract][Full Text] [Related]
2. Conditionally replicative adenovirus-based mda-7/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin.
Xu J; Mo Y; Wang X; Liu J; Zhang X; Wang J; Hu L; Yang C; Chen L; Wang Y
J Gastroenterol; 2013 Feb; 48(2):203-13. PubMed ID: 22820863
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K; Tazawa H; Hasei J; Yamakawa Y; Omori T; Komatsubara T; Mochizuki Y; Kondo H; Osaki S; Fujiwara T; Yoshida A; Kunisada T; Ueda K; Urata Y; Kagawa S; Ozaki T; Fujiwara T
Cancer Chemother Pharmacol; 2021 Sep; 88(3):513-524. PubMed ID: 34114067
[TBL] [Abstract][Full Text] [Related]
4. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
Kaliberova LN; Krendelchtchikova V; Harmon DK; Stockard CR; Petersen AS; Markert JM; Gillespie GY; Grizzle WE; Buchsbaum DJ; Kaliberov SA
Cancer Gene Ther; 2009 Oct; 16(10):794-805. PubMed ID: 19363468
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo.
Zhu W; Wei L; Zhang H; Chen J; Qin X
J Exp Clin Cancer Res; 2012 May; 31(1):51. PubMed ID: 22640485
[TBL] [Abstract][Full Text] [Related]
6. Mda‑7/IL‑24 induces the differentiation of B cell lymphoma via activation of the P38 mitogen activated protein kinase signaling pathway.
Ma M; Yang X; Zhao L; Liu L; Zhang C; Wang X; Shan B
Mol Med Rep; 2017 Oct; 16(4):5633-5642. PubMed ID: 28849038
[TBL] [Abstract][Full Text] [Related]
7. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
Wang Z; Yang L; Xia Y; Guo C; Kong L
Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
[TBL] [Abstract][Full Text] [Related]
8. An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells.
Yuan S; Fang X; Xu Y; Ni A; Liu XY; Chu L
Oncotarget; 2016 Sep; 7(37):60491-60502. PubMed ID: 27528029
[TBL] [Abstract][Full Text] [Related]
9. Lentivirus‑mediated MDA7/IL24 expression inhibits the proliferation of hepatocellular carcinoma cells.
Ma C; Zhao LL; Zhao HJ; Cui JW; Li W; Wang NY
Mol Med Rep; 2018 Apr; 17(4):5764-5773. PubMed ID: 29484443
[TBL] [Abstract][Full Text] [Related]
10. Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer.
Oida Y; Gopalan B; Miyahara R; Inoue S; Branch CD; Mhashilkar AM; Lin E; Bekele BN; Roth JA; Chada S; Ramesh R
Mol Cancer Ther; 2005 Feb; 4(2):291-304. PubMed ID: 15713900
[TBL] [Abstract][Full Text] [Related]
11. Poncirin downregulates ATP-binding cassette transporters to enhance cisplatin sensitivity in cisplatin-resistant osteosarcoma cells.
Zhao L; Zhang W; Zhang F
Phytother Res; 2021 Jan; 35(1):278-288. PubMed ID: 32779800
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.
Xue XB; Xiao CW; Zhang H; Lu AG; Gao W; Zhou ZQ; Guo XL; Zhong MA; Yang Y; Wang CJ
World J Gastroenterol; 2010 Oct; 16(37):4677-84. PubMed ID: 20872968
[TBL] [Abstract][Full Text] [Related]
13. Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.
Avnet S; Lemma S; Cortini M; Pellegrini P; Perut F; Zini N; Kusuzaki K; Chano T; Grisendi G; Dominici M; De Milito A; Baldini N
Oncotarget; 2016 Sep; 7(39):63408-63423. PubMed ID: 27566564
[TBL] [Abstract][Full Text] [Related]
14. CD47-retargeted oncolytic adenovirus armed with melanoma differentiation-associated gene-7/interleukin-24 suppresses in vivo leukemia cell growth.
Li G; Wu H; Cui L; Gao Y; Chen L; Li X; Liang T; Yang X; Cheng J; Luo J
Oncotarget; 2015 Dec; 6(41):43496-507. PubMed ID: 26554307
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus arming human IL-24 inhibits neuroblastoma cell proliferation in vitro and xenograft tumor growth in vivo.
Zhuo B; Wang R; Yin Y; Zhang H; Ma T; Liu F; Cao H; Shi Y
Tumour Biol; 2013 Aug; 34(4):2419-26. PubMed ID: 23609032
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
Nishikawa T; Ramesh R; Munshi A; Chada S; Meyn RE
Mol Ther; 2004 Jun; 9(6):818-28. PubMed ID: 15194048
[TBL] [Abstract][Full Text] [Related]
18. High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma.
Shu H; Yuan B; Huang Y; Wang L; He B; Sun Q; Sun L
J Orthop Surg Res; 2021 Jan; 16(1):85. PubMed ID: 33509236
[TBL] [Abstract][Full Text] [Related]
19. Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.
Xia YZ; Yang L; Xue GM; Zhang C; Guo C; Yang YW; Li SS; Zhang LY; Guo QL; Kong LY
Oncotarget; 2016 Aug; 7(35):56371-56382. PubMed ID: 27486760
[TBL] [Abstract][Full Text] [Related]
20. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]